Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers

Area of Science:

• Environmental Toxicology
• Dermatology
• Molecular Biology

Background:

• The aryl hydrocarbon receptor (AHR) is a transcription factor activated by environmental chemicals, including carcinogens like dioxins and polycyclic aromatic hydrocarbons.
• AHR influences detoxification, cell proliferation, and immune responses, and is increasingly recognized for its role in skin carcinogenesis.

Purpose of the Study:

• To elucidate the multifaceted role of the aryl hydrocarbon receptor (AHR) in the initiation, progression, and treatment of various skin cancers.
• To explore AHR's involvement in mediating the carcinogenic effects of environmental factors like UV radiation and chemical carcinogens.
• To investigate AHR's impact on the efficacy of melanoma therapies.

Main Methods:

• Review and synthesis of existing literature on AHR's function in skin biology and cancer.
• Analysis of AHR's role in regulating genes involved in UV response, DNA repair, and carcinogen metabolism.
• Examination of AHR's influence on therapeutic resistance mechanisms in melanoma, including BRAF inhibitors and PD-1 pathways.

Main Results:

• AHR acts as a susceptibility gene for squamous cell carcinoma and a prognostic factor for melanoma and Merkel cell carcinoma.
• AHR mediates UV-induced inflammation, apoptosis, DNA repair, and metabolic activation of chemical carcinogens in the skin.
• AHR activation contributes to resistance against targeted therapies (BRAF inhibitors) and influences immune checkpoint blockade (PD-1) in melanoma.

Conclusions:

• The aryl hydrocarbon receptor (AHR) is a critical regulator in skin cancer biology, impacting carcinogenesis and therapeutic responses.
• Targeting AHR presents a viable strategy for developing novel chemopreventive and chemotherapeutic agents for skin cancers.
• Further research into AHR modulation could significantly advance the management of skin malignancies.